Filtered By:
Source: Asian Pacific Journal of Cancer Prevention

This page shows you your search results in order of date. This is page number 19.

Order by Relevance | Date

Total 1106 results found since Jan 2013.

Chromium as a Risk Factor for Breast Cancer: A Meta-Analysis
CONCLUSION: The article established that women who live or work in ecologically polluted areas or have problems with micronutrient exchange need in-depth screening and more frequent screening for early detection of pre- and breast cancer.PMID:36579979 | DOI:10.31557/APJCP.2022.23.12.3993
Source: Asian Pacific Journal of Cancer Prevention - December 29, 2022 Category: Cancer & Oncology Authors: Gulnara Batyrova Victoria Kononets Ainur Amanzholkyzy Zhenisgul Tlegenova Gulmira Umarova Source Type: research

Diagnostic Accuracy of Screening of Lip and Oral Cavity Cancers or Potentially Malignant Disorders (PMD) by Frontline Workers: A Systematic Review and Meta-Analysis
Asian Pac J Cancer Prev. 2022 Dec 1;23(12):3983-3991. doi: 10.31557/APJCP.2022.23.12.3983.ABSTRACTBACKGROUND: Oral cancer screening strategies help reduce associated mortality and could be performed by a trained frontline health worker (FHW). The present review aims to assess the diagnostic accuracy of commonly used screening modalities for oral cancer performed by FHW in apparently healthy individuals.METHODS: Electronic databases PubMed, Scopus, Embase, Cochrane Library, and Google Scholar, were searched. The review included studies conducted where apparently healthy adult individuals were screened by the FHW for cancer ...
Source: Asian Pacific Journal of Cancer Prevention - December 29, 2022 Category: Cancer & Oncology Authors: Dahy Sulaiman Ayush Lohiya S A Rizwan Ankita Singh Pooja Dwivedi Pankaj Bahuguna Jyoti Dixit Ankur Verma Vijendra Kumar Source Type: research

Chromium as a Risk Factor for Breast Cancer: A Meta-Analysis
CONCLUSION: The article established that women who live or work in ecologically polluted areas or have problems with micronutrient exchange need in-depth screening and more frequent screening for early detection of pre- and breast cancer.PMID:36579979 | DOI:10.31557/APJCP.2022.23.12.3993
Source: Asian Pacific Journal of Cancer Prevention - December 29, 2022 Category: Cancer & Oncology Authors: Gulnara Batyrova Victoria Kononets Ainur Amanzholkyzy Zhenisgul Tlegenova Gulmira Umarova Source Type: research

Diagnostic Accuracy of Screening of Lip and Oral Cavity Cancers or Potentially Malignant Disorders (PMD) by Frontline Workers: A Systematic Review and Meta-Analysis
Asian Pac J Cancer Prev. 2022 Dec 1;23(12):3983-3991. doi: 10.31557/APJCP.2022.23.12.3983.ABSTRACTBACKGROUND: Oral cancer screening strategies help reduce associated mortality and could be performed by a trained frontline health worker (FHW). The present review aims to assess the diagnostic accuracy of commonly used screening modalities for oral cancer performed by FHW in apparently healthy individuals.METHODS: Electronic databases PubMed, Scopus, Embase, Cochrane Library, and Google Scholar, were searched. The review included studies conducted where apparently healthy adult individuals were screened by the FHW for cancer ...
Source: Asian Pacific Journal of Cancer Prevention - December 29, 2022 Category: Cancer & Oncology Authors: Dahy Sulaiman Ayush Lohiya S A Rizwan Ankita Singh Pooja Dwivedi Pankaj Bahuguna Jyoti Dixit Ankur Verma Vijendra Kumar Source Type: research

Prevalence and Epidemiological Profile of Ameloblastoma in India: A Systematic Review and Meta-Analyses
CONCLUSION: The systematic study indicates a slight male predisposition to ameloblastoma, with a peak incidence in the third decade of life and the mandible as the preferred anatomical site. The solid/multicystic ameloblastoma is the most prevalent histopathologic pattern. More epidemiological research on the prevalence rate of ameloblastoma is required, particularly in India, in an effort to accurately determine the national epidemiological profile of ameloblastoma.PMID:36444570 | DOI:10.31557/APJCP.2022.23.11.3601
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Yoithapprabhunath Thuckanaickenpalayam Ragunathan Srichinthu Keniyan Kumar Dineshshankar Janardhanam Aravindhan Ravi Vidyalakshmi Santhanam Madhavan Nirmal Ramdas Source Type: research

Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization
CONCLUSION: Based on our findings, patients with intermediate-stage HCC who received TACE had a lower median survival time compared to previous studies. However, we identified APRI less than 0.5, tumor size less than 5 cm, and tumor number less than 7 as prognostic factors improving survival time in intermediate-stage HCC patients.PMID:36444608 | DOI:10.31557/APJCP.2022.23.11.3939
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Nakarin Inmutto Natthaphong Nimitrungtawee Tanop Srisuwan Thanate Kattipathanapong Attaporn Jantarangkoon Oranit Puttisri Source Type: research

Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment
CONCLUSIONS: Based on results, the rs1695 polymorphism could not be considered a risk factor for oral cancer.PMID:36444599 | DOI:10.31557/APJCP.2022.23.11.3859
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Ahmadali Baghaei Mohaddeseh Behjati Ali Karimian Source Type: research

Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization
CONCLUSION: Based on our findings, patients with intermediate-stage HCC who received TACE had a lower median survival time compared to previous studies. However, we identified APRI less than 0.5, tumor size less than 5 cm, and tumor number less than 7 as prognostic factors improving survival time in intermediate-stage HCC patients.PMID:36444608 | DOI:10.31557/APJCP.2022.23.11.3939
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Nakarin Inmutto Natthaphong Nimitrungtawee Tanop Srisuwan Thanate Kattipathanapong Attaporn Jantarangkoon Oranit Puttisri Source Type: research

Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment
CONCLUSIONS: Based on results, the rs1695 polymorphism could not be considered a risk factor for oral cancer.PMID:36444599 | DOI:10.31557/APJCP.2022.23.11.3859
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Ahmadali Baghaei Mohaddeseh Behjati Ali Karimian Source Type: research

Prevalence and Epidemiological Profile of Ameloblastoma in India: A Systematic Review and Meta-Analyses
CONCLUSION: The systematic study indicates a slight male predisposition to ameloblastoma, with a peak incidence in the third decade of life and the mandible as the preferred anatomical site. The solid/multicystic ameloblastoma is the most prevalent histopathologic pattern. More epidemiological research on the prevalence rate of ameloblastoma is required, particularly in India, in an effort to accurately determine the national epidemiological profile of ameloblastoma.PMID:36444570 | DOI:10.31557/APJCP.2022.23.11.3601
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Yoithapprabhunath Thuckanaickenpalayam Ragunathan Srichinthu Keniyan Kumar Dineshshankar Janardhanam Aravindhan Ravi Vidyalakshmi Santhanam Madhavan Nirmal Ramdas Source Type: research

Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization
CONCLUSION: Based on our findings, patients with intermediate-stage HCC who received TACE had a lower median survival time compared to previous studies. However, we identified APRI less than 0.5, tumor size less than 5 cm, and tumor number less than 7 as prognostic factors improving survival time in intermediate-stage HCC patients.PMID:36444608 | DOI:10.31557/APJCP.2022.23.11.3939
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Nakarin Inmutto Natthaphong Nimitrungtawee Tanop Srisuwan Thanate Kattipathanapong Attaporn Jantarangkoon Oranit Puttisri Source Type: research

Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment
CONCLUSIONS: Based on results, the rs1695 polymorphism could not be considered a risk factor for oral cancer.PMID:36444599 | DOI:10.31557/APJCP.2022.23.11.3859
Source: Asian Pacific Journal of Cancer Prevention - November 29, 2022 Category: Cancer & Oncology Authors: Ahmadali Baghaei Mohaddeseh Behjati Ali Karimian Source Type: research